Security key
98420N105
Xenon Pharmaceuticals Inc. - COMMON STOCK (XENE)
CUSIP: 98420N105
Q2 2019 13F Holders as of 30 Jun 2019
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 17,563,087
- Total 13F value
- $173,174,992
- Share change
- -156,663
- SEC-reported price per share
- $9.86
- Number of holders
- 59
- Value change
- -$1,947,261
- Number of buys
- 26
- Number of sells
- 21
- Shares outstanding
- 96,697,040
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2019
Institutions
59
Top holders
10
XENE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Xenon Pharmaceuticals Inc. SEC filings
Xenon Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420N105
Recent filing periods:
Ownership snapshot
Top reported holders of XENE - Xenon Pharmaceuticals Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Avoro Capital Advisors LLC
Disclosed value leader
Avoro Capital Advisors LLC
Comparable rows
15/15
Latest evidence
31 Mar 2019
13F
Lead comparable stake: 2.5%
Showing 1-6 of 15 holder rows.
Quick read
Avoro Capital Advisors LLC leads the comparable SEC ownership view at 2.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Avoro Capital Advisors LLC's linked filing trail.
Comparable ownership
Top 5
Avoro Capital Advisors LLC
2.5%
BVF INC/IL
1.8%
Vivo Capital, LLC
1.5%
ADAGE CAPITAL PARTNERS GP, L.L.C.
1.3%
Capital International Investors
1.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC |
13F
Company
|
2.5%
|
$24,384,000
2,400,000 shares
|
— | 31 Mar 2019 |
| BVF INC/IL |
13F
Company
|
1.8%
|
$18,174,000
1,788,774 shares
|
— | 31 Mar 2019 |
| Vivo Capital, LLC |
13F
Company
|
1.5%
|
$14,280,000
1,405,476 shares
|
— | 31 Mar 2019 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
1.3%
|
$13,208,000
1,300,000 shares
|
— | 31 Mar 2019 |
| Capital International Investors |
13F
Company
|
1.1%
|
$10,726,000
1,055,726 shares
|
— | 31 Mar 2019 |
| Capital World Investors |
13F
Company
|
1%
|
$9,789,000
963,500 shares
|
— | 31 Mar 2019 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2019
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
59
Shares
17,563,087
Rows available
59
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
61
Q2 2019 holders
59
Holder diff
-2
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 value | Q2 2019 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend